Overview
Dynamics of Insulin Absorption in Subclinical Lipohypertrophy Using the Euglycemic Clamp Technique
Status:
Suspended
Suspended
Trial end date:
2023-04-01
2023-04-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
This study will use the euglycemic clamp technique to evaluate insulin absorption when insulin is administered subcutaneously in an area of subclinical lipohypertrophy vs an area of normal tissue.Phase:
N/AAccepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Graydon MeneillyTreatments:
Insulin
Insulin Lispro
Insulin, Globin Zinc
Criteria
Inclusion Criteria:- Participated in Glycemic Variability study
- Type 2 Diabetes for at least 2 years
- Currently using insulin to manage diabetes
- Have used insulin to manage diabetes for at least 2 years
- Age 19 or older
- BMI < 30 kg/m2
- Confirmed areas of subclinical lipohypertrophic adipose tissue lesions via ultrasound
Exclusion Criteria:
- Taking other injectable medications (eg liraglutide/Victoza
- Taking systemic steroids (ie prednisone)
- Severe renal insufficiency (eGFR < 30 ml/min/1.73 m2
- Hypoglycemic unawareness
- Current pregnancy
- Not fluent in speaking and writing English (unless accompanied by a translator)